NCT00216229View on ClinicalTrials.gov

Twinrix Alternative Schedule Study

PHASE4UnknownINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

February 28, 2006

Conditions

Antibody Response After Vaccination

Interventions

BIOLOGICAL

Combined vaccine against hepatitis A and B (Twinrix)

Trial Locations (1)

B-3001

IDEWE, Leuven

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

IDEWE Occupational Health Services

OTHER